Faiyaz Shakeel |Pharmaceutical sciences | Best Researcher Award

Posted on by ScienceFather

Ā Prof Dr. Faiyaz Shakeel | Pharmaceutical sciences |Best Researcher Award

Prof Dr. King Saud University, Saudi Arabia

šŸ‘©ā€šŸ”¬Highly accomplished in pharmaceutics, holds a Ph.D. and M. Pharm. from Jamia Hamdard University, India. With extensive experience as a Professor and Associate Professor at King Saud University, Riyadh, Saudi Arabia, and previous roles in academia and research, he excels in formulation research and development. His expertise spans nanoemulsions and transdermal dosage forms, contributing significantly to the field. Driven by a passion for innovation, he led groundbreaking projects, optimizing drug delivery systems for enhanced therapeutic outcomes. Eager to leverage his skills and knowledge, he seeks to join a renowned research organization, fostering growth and advancement in pharmaceutical sciences.šŸŒŸ

 

Profile

 

Scholar

 

šŸŽ“ Ā Objectives

Seeking association with a renowned research organization in formulation research and development to upgrade knowledge, research, and management skills in line with the latest trends. Eager to be part of a dynamic team contributing to organizational growth.

šŸ“š Ā Qualification Overview

Doctor of Philosophy (Ph.D.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2004-2007. Master of Pharmacy (M. Pharm.) in Pharmaceutics, Jamia Hamdard University, New Delhi, India, 2002-2004. Bachelor of Pharmacy (B. Pharm.), Jamia Hamdard University, New Delhi, India, 1998-2002.

šŸ‘Øā€šŸ« Professional Experience

Professor, King Saud University, Riyadh, Saudi Arabia (Feb 2022 – Present) Associate Professor, King Saud University, Riyadh, Saudi Arabia (Mar 2016 – Feb 2022) Assistant Professor, King Saud University, Riyadh, Saudi Arabia (Nov 2011 – Mar 2016) Lecturer, Garyounis University, Benghazi, Libya (Nov 2007 – Nov 2011) Senior Lecturer, Bhawani Shankar Anangpuria Institute of Pharmacy, Faridabad, India (Aug 2006 – Oct 2007) Guest Lecturer, Shri Gopichand College of Pharmacy, Baghpat, India (Jul 2004 – Jun 2006)

šŸ… Ā Professional Qualification

Ph.D. Title: Formulation and development of transdermal dosage form (Nanoemulsions) for antirheumatoid drug, Jamia Hamdard University, New Delhi, India, 2004-2007. M. Pharm. Title: Development and evaluation of bioadhesive transdermal gels of diclofenac diethylamine, Jamia Hamdard University, New Delhi, India, 2002-2004. B. Pharm., Jamia Hamdard University, New Delhi, India, 1998-2002.

šŸ”¬Ā Practical Experience

Master’s Research Project: Developed bioadhesive transdermal gels for diclofenac diethylamine. Ph.D. Thesis: Developed nanoemulsion and nanoemulsion gel formulations of celecoxib and aceclofenac for arthritis.

šŸ”Conclusion of Research Projects

Master’s Project: Optimized gel showed controlled drug release and significant anti-inflammatory effects. Ph.D. Thesis: Developed nanoemulsion formulations with controlled release, higher absorption, and significant pharmacodynamic effects.

Publications Top Notes šŸ“

  • Development and bioavailability assessment of ramipril nanoemulsion formulation
    • Authors: S Shafiq, F Shakeel, S Talegaonkar, FJ Ahmad, RK Khar, M Ali
    • Journal: European journal of pharmaceutics and biopharmaceutics
    • Year: 2007
    • Volume: 66
    • Issue: 2
    • Pages: 227-243
    • Citations: 1006

 

  • Nanoemulsions as vehicles for transdermal delivery of aceclofenac
    • Authors: F Shakeel, S Baboota, A Ahuja, J Ali, M Aqil, S Shafiq
    • Journal: Aaps Pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: 191-199
    • Citations: 427

 

  • Formulation development and optimization using nanoemulsion technique: a technical note
    • Authors: S Shafiq-un-Nabi, F Shakeel, S Talegaonkar, J Ali, S Baboota, A Ahuja, …
    • Journal: AAPS pharmscitech
    • Year: 2007
    • Volume: 8
    • Pages: E12-E17
    • Citations: 420

 

  • Design, development and evaluation of novel nanoemulsion formulations for transdermal potential of celecoxib
    • Authors: S Baboota, F Shakeel, A Ahuja, J Ali, S Shafiq
    • Journal: Acta pharmaceutica
    • Year: 2007
    • Volume: 57
    • Issue: 3
    • Pages: 315-332
    • Citations: 397

 

  • A review on the strategies for oral delivery of proteins and peptides and their clinical perspectives
    • Authors: A Muheem, F Shakeel, MA Jahangir, M Anwar, N Mallick, GK Jain, …
    • Journal: Saudi Pharmaceutical Journal
    • Year: 2016
    • Volume: 24
    • Issue: 4
    • Pages: 413-428
    • Citations: 384

 

Ravi Kumar Rajan | Ethnopharmacology | Young Scientist Award

Posted on by ScienceFather

Assist Prof Dr. Ravi Kumar Rajan | Ethnopharmacology | Young Scientist Award

šŸ‘Øā€šŸ«Profile Summary

As a pharmacy graduate, I am highly results-oriented and driven by objectives. My eagerness to learn new techniques and apply them effectively sets me apart. I excel at observing and troubleshooting problems, making me well-suited for careers in academia, pharmaceuticals, research and development (R&D), or clinical practice. With a strong foundation in pharmacy, I am ready to contribute meaningfully to any role I undertake and make a positive impact in the field.

šŸŒ Professional Profiles

 

šŸŽ“Ā  Education

  • Ph.D. (Awarded on June 2022) in Pharmacy and Pharmaceutical Sciences from The Tamil Nadu Dr. MGR Medical University, Guindy, Chennai, Tamil Nadu.
  • Master of Pharmacy (2012-2014), specialized in Pharmacology & Toxicology, from PSG College of Pharmacy, Coimbatore, Tamil Nadu.
  • Bachelor of Pharmacy (2008-2012) from Swamy Vivekanandha College of Pharmacy, Elayampalayam, Tiruchengode, Tamil Nadu.

šŸ”¬Research Experience

  • Junior Research Fellowship under ā€˜DST- New Delhiā€™ focused on “Biogenic Synthesis of Silver Nanoconjugates with Natural Products for Breast Cancer” from December 2014 to December 2017.

šŸ” Project

Ph.D. Project (2017-2020): Conducted Pre-clinical Evaluation of Neuroprotective Effects of Terpenes/Terpenoids and Stilbenoids in Ischemic Disease. Post-graduate Project (2013-2014): Evaluated soy isoflavones in letrozole-induced rat model of polycystic ovary syndrome. Undergraduate Project (2012-2013): Investigated the Effect of Hybanthus Enneaspermus in Streptozotocin-Nicotinamide Induced Type 2 Diabetes in Male Albino Rats.

šŸ† Awards & Achievements

  • Secured Second Prize (2019) on the National level for Best Poster in the “7th PhD Poster Symposium on Chemistry and Biology Interface” jointly organized by the Royal Society of Chemistry (London) ā€“ Indian Deccan Local Section and National Institute of Pharmaceutical Education and Research (NIPER) Hyderabad.

šŸ“œĀ  Certificates

“COVID-19 Contact Tracing” Course Certificate by COURSERA offered by JOHNS HOPKINS UNIVERSITY (June 2020). “Advanced Schrƶdinger Workshop” Hands-on training conducted at Schrƶdinger Office, Bangalore, focusing on Computer-Aided Drug Design (2020). “Computer-Aided Molecular Modeling and Dynamics” Hands-on training and workshop organized by the Department of Pharmacology, PSG College of Pharmacy, Coimbatore, Tamil Nadu (2019). “Molecular Modeling and Drug Discovery ā€“ Workshop IV” conducted by the Department of Pharmacology, PSG College of Pharmacy (2015). “Molecular Modeling and Drug Discovery ā€“ Workshop II” conducted by the Department of Pharmacology, PSG College of Pharmacy (2013).

šŸ“šTop Noted Publication

Title: Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism

  • Authors: RK Rajan, B Balaji
  • Year: 2017

 

Title: Crystal structure, Hirshfeld surface analysis, DFT and molecular docking studies on benzohydrazide derivatives as potential inhibitors of prostate cancer

  • Authors: HA Arjun, RK Rajan, R Elancheran, M Ramanathan, A Bhattacharjee
  • Year: 2020

 

Title: Design, Synthesis, and Biological Evaluation of 2ā€(2ā€Bromoā€3ā€nitrophenyl)ā€5ā€phenylā€1, 3, 4ā€oxadiazole Derivatives as Possible Antiā€Breast Cancer Agents

  • Authors: AH Ananth, N Manikandan, RK Rajan, R Elancheran, K Lakshmithendral
  • Year: 2020

 

Title: Synthesis and characterization of folic acid conjugated gemcitabine tethered silver nanoparticles (FA-GEM-AgNPs) for targeted delivery

  • Authors: A Karuppaiah, R Rajan, S Hariharan, DK Balasubramaniam, M Gregory
  • Year: 2020

 

Title: Building and Behavior of A pH-Stimuli Responsive Chitosan Nanoparticles Loaded with Folic Acid Conjugated Gemcitabine Silver Colloids In MDA-MB-453 Metastatic Breast Cancer

  • Authors: Arjunan Karuppaiah, Dinesh Babu, Divakar Selvaraj, Tamilselvan Natrajan
  • Year: 2021

 

Title: Cytotoxicity and synergistic effect of biogenically synthesized ternary therapeutic nano conjugates comprising plant active principle, silver and anticancer drug on MDA-MB-453

  • Authors: A Karuppaiah, R Rajan, M Ramanathan, A Nagarajan
  • Year: 2020

 

Title: Identification and neuroprotective evaluation of a potential c-Jun N-terminal kinase 3 inhibitor through structure-based virtual screening and in-vitro assay

  • Authors: RK Rajan, M Ramanathan
  • Year: 2020

 

Title: Cā€“Glucosyl Xanthone derivative Mangiferin downregulates the JNK3 mediated caspase activation in Almal induced neurotoxicity in differentiated SHSY-5Y neuroblastoma cells

  • Authors: N Pk, RK Rajan, V Nanchappan, A Karuppaiah, J Chandrasekaran
  • Year: 2023

 

Title: In-silico and in-vitro analysis of novel substituted benzimidazolyl derivatives for antimycobacterial potentials targeting enoyl acyl carrier protein reductase (InhA)

  • Authors: U Kuppuswamy, RK Rajan, A Kumar, M Ramanathan
  • Year: 2022

 

Title: Piceatannol selectively inhibited the JNK3 enzyme and augmented apoptosis through inhibition of Bcl-2/Cyt-c/caspase-dependent pathways in the oxygenā€“glucose deprived SHSY-5Y

  • Authors: RKRM Ramanathan
  • Year: 2024

 

Title: Piceatannol improved cerebral blood flow and attenuated JNK3 and mitochondrial apoptotic pathway in a global ischemic model to produce neuroprotection

  • Authors: RK Rajan, RP Kumar, M Ramanathan
  • Year: 2024